UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037636
Receipt number R000042905
Scientific Title Evaluation of nursing intervention program for promoting to sense of coherence of recurrence breast cancer patients who received chemotherapy
Date of disclosure of the study information 2019/08/15
Last modified on 2022/02/08 14:59:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of nursing intervention program for promoting to sense of coherence of recurrence breast cancer patients who received chemotherapy

Acronym

Evaluation of nursing intervention for promoting to sense of coherence of recurrence breast cancer patients

Scientific Title

Evaluation of nursing intervention program for promoting to sense of coherence of recurrence breast cancer patients who received chemotherapy

Scientific Title:Acronym

Evaluation of nursing intervention for promoting to sense of coherence of recurrence breast cancer patients

Region

Japan


Condition

Condition

recurrence breast cancer

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to clarify the effectiveness and usefulness of the nursing intervention program for promote the SOC of breast cancer patients diagnosed with recurrence and undergoing chemotherapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Anxiety and depression;Hospital Anxiety and Depression Scale

Key secondary outcomes

Sense of coherence;Sense of coherence Scale
Quality of Life;SF-12v2


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

The goal of the program is to improve SOC, to decrease anxiety and depression, and to restore QOL for the patients. The program addresses;support patients to express negative emotions and to sort through emotions and thoughts, assist patients to obtain information of the recurrent cancer and chemotherapy, and support patients to cope constructively with negative emotions. We decided to intervene with the narrative approach. The intervention period was one and a half months from the start of the first chemotherapy, and there were three times interventions.

Interventions/Control_2

Control group;Receive regular care of the nurse at the facility.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

79 years-old >=

Gender

Female

Key inclusion criteria

1.A female breast cancer patient who has distant metastasis and undergoing chemotherapy.
2.Chemotherapy includes oral anti-cancer drugs and drip anti-cancer drugs including molecular targeted drugs.

Key exclusion criteria

1.Breast cancer patients with local recurrence
2.Breast cancer patients with first advanced cancer
3.Recurrent breast cancer patients who receive endocrine therapy, radiation therapy, surgery, or immunotherapy alone
4.Patients who have relapsed and are receiving multiple times chemotherapy
5.Patients who appear to be in confusion or panic

Target sample size

5


Research contact person

Name of lead principal investigator

1st name KUMI
Middle name
Last name SUZUKI

Organization

Osaka Medical and Pharmaceutical University

Division name

Faculty of Nursing

Zip code

569-0095

Address

7-6, Hatchonishi-machi, Takatsuki, Osaka

TEL

072-684-7281

Email

kumi.suzuki@ompu.ac.jp


Public contact

Name of contact person

1st name KUMI
Middle name
Last name SUZUKI

Organization

Osaka Medical and Pharmaceutical University

Division name

Faculty of Nursing

Zip code

569-0095

Address

7-6, Hatchonishi-machi, Takatsuki, Osaka

TEL

072-684-7281

Homepage URL


Email

kumi.suzuki@ompu.ac.jp


Sponsor or person

Institute

Osaka Medical and Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka Medical and Pharmaceutical University hospital
Yodogawa christian hospital
Hyogo prefectural nishinomiya hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Osaka Medical and Pharmaceutical University

Address

2-7 Daigaku-machi, Takatsuki, Osaka

Tel

072-683-1221

Email

rinri@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪医科薬科大学(大阪府)


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

5

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2022 Year 03 Month 25 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 05 Month 10 Day

Date of IRB

2019 Year 05 Month 10 Day

Anticipated trial start date

2019 Year 07 Month 26 Day

Last follow-up date

2021 Year 10 Month 31 Day

Date of closure to data entry

2021 Year 10 Month 31 Day

Date trial data considered complete

2021 Year 10 Month 31 Day

Date analysis concluded

2021 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2019 Year 08 Month 08 Day

Last modified on

2022 Year 02 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042905


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name